Page last updated: 2024-09-05

organophosphonates and fk 866

organophosphonates has been researched along with fk 866 in 1 studies

Compound Research Comparison

Studies
(organophosphonates)
Trials
(organophosphonates)
Recent Studies (post-2010)
(organophosphonates)
Studies
(fk 866)
Trials
(fk 866)
Recent Studies (post-2010) (fk 866)
9,9688803,5961883154

Protein Interaction Comparison

ProteinTaxonomyorganophosphonates (IC50)fk 866 (IC50)
Cytochrome P450 1A2Homo sapiens (human)0.001
Cytochrome P450 3A4Homo sapiens (human)0.001
Cytochrome P450 2C9 Homo sapiens (human)0.001
Cytochrome P450 2C19Homo sapiens (human)0.001
Nicotinamide phosphoribosyltransferaseHomo sapiens (human)0.0095
Nicotinamide phosphoribosyltransferaseMus musculus (house mouse)0.0038

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berenbaum, F; Gosset, M; Holzenberger, M; Jacques, C; Mladenovic, Z; Pecchi, E; Salvat, C1

Other Studies

1 other study(ies) available for organophosphonates and fk 866

ArticleYear
Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity.
    The Journal of biological chemistry, 2012, Apr-27, Volume: 287, Issue:18

    Topics: Acrylamides; Animals; Cells, Cultured; Chondrocytes; Cytokines; Dinoprostone; Gene Expression Regulation; Humans; Inflammation; Insulin; Mice; Mice, Knockout; Naphthalenes; Nicotinamide Phosphoribosyltransferase; Organophosphonates; Piperidines; Receptor, IGF Type 1; Receptor, Insulin; Signal Transduction

2012